Found: 77
Select item for more details and to access through your institution.
Cross‐Link‐Functionalized Nanoparticles for Rapid Excretion in Nanotheranostic Applications.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 46, p. 20733, doi. 10.1002/ange.202008083
- By:
- Publication type:
- Article
Aligning physics and physiology: Engineering antibodies for radionuclide delivery.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2018, v. 61, n. 9, p. 693, doi. 10.1002/jlcr.3622
- By:
- Publication type:
- Article
Activatable fluorescent cys-diabody conjugated with indocyanine green derivative: consideration of fluorescent catabolite kinetics on molecular imaging.
- Published in:
- Journal of Biomedical Optics, 2013, v. 18, n. 10, p. 1, doi. 10.1117/1.JBO.18.10.101304
- By:
- Publication type:
- Article
Artificial intelligence in immunotherapy PET/SPECT imaging.
- Published in:
- European Radiology, 2024, v. 34, n. 9, p. 5829, doi. 10.1007/s00330-024-10637-3
- By:
- Publication type:
- Article
Characterization of a double-sided silicon strip detector autoradiography system.
- Published in:
- Medical Physics, 2015, v. 42, n. 2, p. 575, doi. 10.1118/1.4905049
- By:
- Publication type:
- Article
Integrating Artificial Intelligence and PET Imaging for Drug Discovery: A Paradigm Shift in Immunotherapy.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 2, p. 210, doi. 10.3390/ph17020210
- By:
- Publication type:
- Article
Biodistribution of Intra-Arterial and Intravenous Delivery of Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles in a Rat Model to Guide Delivery Strategies for Diabetes Therapies.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 5, p. 595, doi. 10.3390/ph15050595
- By:
- Publication type:
- Article
Arming antibodies: prospects and challenges for immunoconjugates.
- Published in:
- Nature Biotechnology, 2005, v. 23, n. 9, p. 1137, doi. 10.1038/nbt1141
- By:
- Publication type:
- Article
Red-shifted Renilla reniformis luciferase variants for imaging in living subjects.
- Published in:
- Nature Methods, 2007, v. 4, n. 8, p. 641, doi. 10.1038/nmeth1070
- By:
- Publication type:
- Article
Levels of Murine, but Not Human, CXCL13 Are Greatly Elevated in NOD-SCID Mice Bearing the AIDS-Associated Burkitt Lymphoma Cell Line, 2F7.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0072414
- By:
- Publication type:
- Article
Neural Stem Cells as a Novel Platform for Tumor-Specific Delivery of Therapeutic Antibodies.
- Published in:
- PLoS ONE, 2009, v. 4, n. 12, p. 1, doi. 10.1371/journal.pone.0008314
- By:
- Publication type:
- Article
Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 4/5, p. 243, doi. 10.1007/s002620000115
- By:
- Publication type:
- Article
ImmunoPET: harnessing antibodies for imaging immune cells.
- Published in:
- Molecular Imaging & Biology, 2022, v. 24, n. 2, p. 181, doi. 10.1007/s11307-021-01652-7
- By:
- Publication type:
- Article
Evaluation of [<sup>131</sup>I]I- and [<sup>177</sup>Lu]Lu-DTPA-A11 Minibody for Radioimmunotherapy in a Preclinical Model of PSCA-Expressing Prostate Cancer.
- Published in:
- Molecular Imaging & Biology, 2020, v. 22, n. 5, p. 1380, doi. 10.1007/s11307-020-01518-4
- By:
- Publication type:
- Article
[<sup>89</sup>Zr]A2cDb Immuno-PET of Prostate Cancer in a Human Prostate Stem Cell Antigen Knock-in (hPSCA KI) Syngeneic Model.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Enhanced Growth Inhibition of Osteosarcoma by Cytotoxic Polymerized Liposomal Nanoparticles Targeting the Alcam Cell Surface Receptor.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Enhanced Growth Inhibition of Osteosarcoma by Cytotoxic Polymerized Liposomal Nanoparticles Targeting the Alcam Cell Surface Receptor.
- Published in:
- Sarcoma, 2012, p. 1, doi. 10.1155/2012/126906
- By:
- Publication type:
- Article
Development and implementation of a science training course for breast cancer activists: Project LEAD (leadership, education and advocacy development).
- Published in:
- Health Expectations, 2001, v. 4, n. 4, p. 213, doi. 10.1046/j.1369-6513.2001.00153.x
- By:
- Publication type:
- Article
Targeted alpha therapy with astatine-211-labeled anti-PSCA A11 minibody shows antitumor efficacy in prostate cancer xenografts and bone microtumors.
- Published in:
- EJNMMI Research, 2020, v. 10, n. 1, p. 1, doi. 10.1186/s13550-020-0600-z
- By:
- Publication type:
- Article
Multimerization of a chimeric anti-CD20 single-chain Fv-Fc fusion protein is mediated through variable domain exchange.
- Published in:
- Protein Engineering, 2001, v. 14, n. 12, p. 1025, doi. 10.1093/protein/14.12.1025
- By:
- Publication type:
- Article
An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumors.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2010, v. 37, n. 8, p. 1529, doi. 10.1007/s00259-010-1433-1
- By:
- Publication type:
- Article
Recombinant carcinoembryonic antigen as a reporter gene for molecular imaging.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2009, v. 36, n. 1, p. 104, doi. 10.1007/s00259-008-0921-z
- By:
- Publication type:
- Article
Cross‐Link‐Functionalized Nanoparticles for Rapid Excretion in Nanotheranostic Applications.
- Published in:
- Angewandte Chemie International Edition, 2020, v. 59, n. 46, p. 20552, doi. 10.1002/anie.202008083
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
Title: CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 8, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
Title: CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 1, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
Title: CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
First-in-human imaging with <sup>89</sup>Zr-Df-IAB22M2C anti-CD8 minibody in patients with solid malignancies: preliminary pharmacokinetics, biodistribution, and lesion targeting.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.229781
- By:
- Publication type:
- Article
A dual-modality linker enables site-specific conjugation of antibody fragments for <sup>18</sup>F-immunoPET and fluorescence imaging.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.223560
- By:
- Publication type:
- Article
A Dual-Modality Linker Enables Site-Specific Conjugation of Antibody Fragments for <sup>18</sup>F-Immuno-PET and Fluorescence Imaging.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 10, p. 1467, doi. 10.2967/jnumed.118.223560
- By:
- Publication type:
- Article
Dual-Modality Immuno-PET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using an Anti–Prostate Stem Cell Antigen Cys-Diabody.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 9, p. 1398, doi. 10.2967/jnumed.117.207332
- By:
- Publication type:
- Article
Immuno-PET in Inflammatory Bowel Disease: Imaging CD4-Positive T Cells in a Murine Model of Colitis.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 6, p. 980, doi. 10.2967/jnumed.117.199075
- By:
- Publication type:
- Article
Immune Modulation Therapy and Imaging: Workshop Report.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 3, p. 410, doi. 10.2967/jnumed.117.195610
- By:
- Publication type:
- Article
First-in-Human Imaging with <sup>89</sup>Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 12, p. 1858, doi. 10.2967/jnumed.116.176206
- By:
- Publication type:
- Article
Immuno-PET of Murine T Cell Reconstitution Postadoptive Stem Cell Transplantation Using Anti-CD4 and Anti-CD8 Cys-Diabodies.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 8, p. 1258, doi. 10.2967/jnumed.114.153338
- By:
- Publication type:
- Article
Photoimmunotherapy Targeting Prostate-Specific Membrane Antigen: Are Antibody Fragments as Effective as Antibodies?
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 1, p. 140, doi. 10.2967/jnumed.114.149526
- By:
- Publication type:
- Article
Improved Modeling of In Vivo Kinetics of Slowly Diffusing Radiotracers for Tumor Imaging.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 9, p. 1539, doi. 10.2967/jnumed.114.140038
- By:
- Publication type:
- Article
Quantitative ImmunoPET of Prostate Cancer Xenografts with <sup>89</sup>Zr- and <sup>124</sup>I-Labeled Anti-PSCA A11 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 3, p. 452, doi. 10.2967/jnumed.113.120873
- By:
- Publication type:
- Article
Recombinant Anti-CD20 Antibody Fragments for Small-Animal PET Imaging of B-Cell Lymphomas.
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 9, p. 1500, doi. 10.2967/jnumed.108.060426
- By:
- Publication type:
- Article
Antibodies and Antimatter: The Resurgence of Immuno-PET.
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 1, p. 2, doi. 10.2967/jnumed.108.056887
- By:
- Publication type:
- Article
Engineered Antibody Fragments with Infinite Affinity as Reporter Genes for PET Imaging.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 11, p. 1828, doi. 10.2967/jnumed.108.054452
- By:
- Publication type:
- Article
Truncation of blood curves to enhance imaging and therapy with monoclonal antibodies.
- Published in:
- Medical Physics, 2000, v. 27, n. 5, p. 988, doi. 10.1118/1.598963
- By:
- Publication type:
- Article